Atlas Trials

Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia

Clinical trial NCT06058572 · RECRUITING

Trial details

NCT number
NCT06058572
Sponsor
Tata Memorial Centre
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Leukemia
Start date
2024-08-02
Primary completion
2027-08-02
Enrollment
166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.